Laboratorios Farmaceúticos Rovi SA (LABFF)
65.86
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Laboratorios Farmaceúticos Rovi Profit Margin (Quarterly) : 6.20% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 6.20% |
| December 31, 2025 | 19.53% |
| September 30, 2025 | 27.56% |
| June 30, 2025 | 13.54% |
| March 31, 2025 | 11.67% |
| December 31, 2024 | 11.75% |
| September 30, 2024 | 29.39% |
| June 30, 2024 | 16.49% |
| March 31, 2024 | 9.90% |
| December 31, 2023 | 21.94% |
| September 30, 2023 | 24.38% |
| June 30, 2023 | 10.71% |
| March 31, 2023 | 23.54% |
| December 31, 2022 | 32.27% |
| September 30, 2022 | 20.97% |
| June 30, 2022 | 15.75% |
| March 31, 2022 | 25.80% |
| December 31, 2021 | 29.24% |
| September 30, 2021 | 27.62% |
| June 30, 2021 | 17.04% |
| March 31, 2021 | 18.26% |
| December 31, 2020 | 12.08% |
| September 30, 2020 | 15.52% |
| June 30, 2020 | 17.38% |
| March 31, 2020 | 13.79% |
| Date | Value |
|---|---|
| December 31, 2019 | 7.77% |
| September 30, 2019 | 15.57% |
| June 30, 2019 | 9.71% |
| March 31, 2019 | 8.40% |
| December 31, 2018 | 2.66% |
| September 30, 2018 | 11.16% |
| June 30, 2018 | 1.01% |
| March 31, 2018 | 9.02% |
| December 31, 2017 | 0.31% |
| September 30, 2017 | 1.95% |
| June 30, 2017 | 13.16% |
| March 31, 2017 | 9.45% |
| December 31, 2016 | 6.21% |
| September 30, 2016 | 5.61% |
| June 30, 2016 | 12.61% |
| March 31, 2016 | 15.50% |
| December 31, 2015 | 4.83% |
| September 30, 2015 | 5.21% |
| June 30, 2015 | 11.77% |
| March 31, 2015 | 10.62% |
| December 31, 2014 | 6.57% |
| September 30, 2014 | 8.61% |
| June 30, 2014 | 15.38% |
| March 31, 2014 | 10.29% |
| December 31, 2013 | 7.67% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Almirall SA | -- |
| AstraZeneca PLC | 20.15% |
| ANI Pharmaceuticals, Inc. | 11.55% |
| Corcept Therapeutics, Inc. | -18.92% |
| Assertio Holdings, Inc. | -189.8% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 20.96% |
| Return on Assets | 14.79% |
| Return on Invested Capital | 17.63% |
| Gross Profit Margin (Quarterly) | 55.56% |
| Operating Margin (Quarterly) | 6.48% |
| Return on Net Operating Assets | 16.44% |